Seeking Alpha

Isis Pharmaceuticals (ISIS +3.6%) bounces back solidly from early losses to trade higher, flying...

Isis Pharmaceuticals (ISIS +3.6%) bounces back solidly from early losses to trade higher, flying in the face of an earlier decision by the EMA'w Committee for Medicinal Products for Human Use to adopt a negative opinion for the marketing authorization of Isis' cholesterol drug Kynamro. The drug is being developed jointly with Sanofi (SNY +0.5%) subsidiary Genzyme.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector